Engineering isogenic neuronal models of ATXN3 knockout in Machado-Joseph Disease patient cells by CRISPR/Cas9

被引:0
|
作者
Fernandes, A. R. [1 ,2 ,3 ]
Adao, D. [1 ,3 ]
Lopes, S. M. [1 ,2 ,3 ]
Henriques, D. [1 ,2 ,3 ]
Pena, F. [1 ,2 ,3 ]
Dias, M. [1 ,3 ]
Santana, M. M. [1 ,2 ,3 ]
Perdigao, P. [1 ,2 ,3 ]
Almeida, L. P. [1 ,3 ,4 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Inst Interdisciplinary Res, Coimbra, Portugal
[3] Univ Coimbra, Ctr Innovat Biomed & Biotechnol, Coimbra, Portugal
[4] Univ Coimbra, Fac Pharm, Coimbra, Portugal
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
P297
引用
收藏
页码:A142 / A143
页数:2
相关论文
共 45 条
  • [31] Increasing transgene expression and stability in recombinant CHO cells with DNA methyltransferase Dnmt3b gene knockout via CRISPR/Cas9
    Feng, Ying-Ping
    Lu, Jiang-Tao
    Xiao, Meng-Ke
    Jia, Yan-Long
    Wang, Tian-Yun
    FASEB JOURNAL, 2021, 35
  • [32] Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells
    Wang, Xu
    Zhao, Yang
    Wang, Zhan
    Liao, Zhangcheng
    Zhang, Yushi
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2022, 80 (04) : 681 - 687
  • [33] Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells
    Xu Wang
    Yang Zhao
    Zhan Wang
    Zhangcheng Liao
    Yushi Zhang
    Cell Biochemistry and Biophysics, 2022, 80 : 681 - 687
  • [34] Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells
    Laugel, Bruno
    Lloyd, Angharad
    Meermeier, Erin W.
    Crowther, Michael D.
    Connor, Thomas R.
    Dolton, Garry
    Miles, John J.
    Burrows, Scott R.
    Gold, Marielle C.
    Lewinsohn, David M.
    Sewell, Andrew K.
    JOURNAL OF IMMUNOLOGY, 2016, 197 (03): : 971 - 982
  • [35] CRISPR/Cas9 mediated CXCL4 knockout in human iPS cells of polycythemia vera patient with JAK2 V617F mutation
    Boehnke, Janik
    Atakhanov, Salim
    Toledo, Marcelo A. S.
    Schueler, Herdit M.
    Sontag, Stephanie
    Chatain, Nicolas
    Koschmieder, Steffen
    Bruemmendorf, Tim H.
    Kramann, Rafael
    Zenke, Martin
    STEM CELL RESEARCH, 2021, 55
  • [36] Establishment of heterozygous and homozygous SHANK3 knockout clonal pluripotent stem cells from the parental hESC line SA001 using CRISPR/Cas9
    Chatrousse, Laure
    Poullion, Thifaine
    El-Kassar, Lina
    Giraud-Triboult, Karine
    Boissart, Claire
    Sanatine, Peggy
    Sommer, Peter
    Benchoua, Alexandra
    STEM CELL RESEARCH, 2023, 72
  • [37] CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells
    Lang He
    Shang Wang
    Linliu Peng
    Huifang Zhao
    Shuai Li
    Xiaobo Han
    Jean de Dieu Habimana
    Zhao Chen
    Chunrong Wang
    Yun Peng
    Huirong Peng
    Yue Xie
    Lijing Lei
    Qi Deng
    Linlin Wan
    Na Wan
    Hongyu Yuan
    Yiqing Gong
    Guangdong Zou
    Zhiyuan Li
    Beisha Tang
    Hong Jiang
    Translational Psychiatry, 11
  • [38] CRISPR/Cas9 mediated gene correction ameliorates abnormal phenotypes in spinocerebellar ataxia type 3 patient-derived induced pluripotent stem cells
    He, Lang
    Wang, Shang
    Peng, Linliu
    Zhao, Huifang
    Li, Shuai
    Han, Xiaobo
    Habimana, Jean de Dieu
    Chen, Zhao
    Wang, Chunrong
    Peng, Yun
    Peng, Huirong
    Xie, Yue
    Lei, Lijing
    Deng, Qi
    Wan, Linlin
    Wan, Na
    Yuan, Hongyu
    Gong, Yiqing
    Zou, Guangdong
    Li, Zhiyuan
    Tang, Beisha
    Jiang, Hong
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [39] Reversal of mitochondrial abnormalities by CRISPR/Cas9 editing of the mutant HTT allele in vitro in Huntington's Disease patient-derived pluripotent and neural stem cells
    Lopes, Carla
    Schlaeger, Thorsten
    de Almeida, Luis Pereira
    Daley, George
    Rego, Cristina
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 : 57 - 58
  • [40] WT1 and DNMT3A Play an Essential Function and Represent Therapeutic Vulnerabilities in Certain AML Samples, As Shown By CRISPR/Cas9 Mediated Knockout in PDX Models In Vivo
    Ghalandary, Maryam
    Gao, Yuqiao
    Becker, Martin
    Amend, Diana
    Metzeler, Klaus H.
    Rothenberg-Thurley, Maja
    Jeremias, Irmela
    BLOOD, 2021, 138